TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 313

Author

Pharma Journalist 8916 posts 0 comments

Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)

Jan 3, 2022
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a premier…
Read More...

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Jan 3, 2022
Novo Nordisk announced that the acquisition of Dicerna Pharmaceuticals, Inc. announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender…
Read More...

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Jan 3, 2022
Ionis Pharmaceuticals, Inc. announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis' investigational antisense medicine for…
Read More...

Amphastar Receives FDA Tentative Approval for Vasopressin

Jan 3, 2022
Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has tentatively approved the Company's Abbreviated New Drug Application for Vasopressin injection,…
Read More...

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral…

Jan 3, 2022
Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The…
Read More...

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment…

Jan 3, 2022
Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization…
Read More...

Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference

Dec 20, 2021
SMi Group reports: Scientists to join 3rd Annual AI in Drug Discovery Conference to learn about the breakthroughs in clinical trials in ai drug discovery SMi’s 3rd Annual AI in Drug…
Read More...

Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from…

Dec 20, 2021
SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development…
Read More...

The Transdermal and Microneedle Drug Delivery Conference 2022 is now a Virtual Event: Online Access…

Dec 20, 2021
SMi Reports: Event Announcement: Transdermal and Microneedle Drug Delivery, January 12-13th January 2021 is now a virtual event. Access will be fully online meaning therefore…
Read More...

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference – A Virtual Conference with Online…

Dec 20, 2021
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only…
Read More...
Prev Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.